Clinical Trial Update: Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial sponsored by Amgen evaluated treatment for anemia in patients with non-myeloid malignancies undergoing multicycle chemotherapy; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Cancer

Snippet

Sponsor: Amgen | Conditions: Anemia, Non-Myeloid Malignancies | Phase 3 | Status: COMPLETED